USA Infectious Diseases Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Infectious Diseases market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Infectious Diseases market. Detailed analysis of key players, along with key growth strategies adopted by Infectious Diseases industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • AstraZeneca

    • Johnson & Johnson

    • Eli Lilly

    • Sanofi

    • Novartis

    • Mitsubishi Tanabe Pharma

    • Gilead Sciences

    • AbbVie

    • Pfizer

    • Cubist

    • Merck

    • F Hoffmann-La Roche

    • Isis Pharmaceuticals

    • GlaxoSmithKline

    • Chimerix Pharmaceuticals

    • Bristol-Myers Squibb

    • Bayer

    • Vertex

    • Astellas Pharma

    By Type:

    • Influenza

    • HPV

    • Hepatitis

    • HIV

    • Tuberculosis

    • Others

    By End-User:

    • Hospitals/Clinical Laboratories

    • Reference Laboratories

    • Physician Offices

    • Academic/Research Institutes

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Infectious Diseases Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Infectious Diseases Market Size and Growth Rate of Influenza from 2016 to 2027

      • 1.3.2 USA Infectious Diseases Market Size and Growth Rate of HPV from 2016 to 2027

      • 1.3.3 USA Infectious Diseases Market Size and Growth Rate of Hepatitis from 2016 to 2027

      • 1.3.4 USA Infectious Diseases Market Size and Growth Rate of HIV from 2016 to 2027

      • 1.3.5 USA Infectious Diseases Market Size and Growth Rate of Tuberculosis from 2016 to 2027

      • 1.3.6 USA Infectious Diseases Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Infectious Diseases Market Size and Growth Rate of Hospitals/Clinical Laboratories from 2016 to 2027

      • 1.4.2 USA Infectious Diseases Market Size and Growth Rate of Reference Laboratories from 2016 to 2027

      • 1.4.3 USA Infectious Diseases Market Size and Growth Rate of Physician Offices from 2016 to 2027

      • 1.4.4 USA Infectious Diseases Market Size and Growth Rate of Academic/Research Institutes from 2016 to 2027

      • 1.4.5 USA Infectious Diseases Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Infectious Diseases Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Infectious Diseases Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Infectious Diseases Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Infectious Diseases Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Infectious Diseases Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Infectious Diseases by Major Types

      • 3.4.1 Market Size and Growth Rate of Influenza

      • 3.4.2 Market Size and Growth Rate of HPV

      • 3.4.3 Market Size and Growth Rate of Hepatitis

      • 3.4.4 Market Size and Growth Rate of HIV

      • 3.4.5 Market Size and Growth Rate of Tuberculosis

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Infectious Diseases Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Infectious Diseases by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Infectious Diseases in Hospitals/Clinical Laboratories

      • 4.4.2 Market Size and Growth Rate of Infectious Diseases in Reference Laboratories

      • 4.4.3 Market Size and Growth Rate of Infectious Diseases in Physician Offices

      • 4.4.4 Market Size and Growth Rate of Infectious Diseases in Academic/Research Institutes

      • 4.4.5 Market Size and Growth Rate of Infectious Diseases in Other

    5 Market Analysis by Regions

    • 5.1 USA Infectious Diseases Production Analysis by Regions

    • 5.2 USA Infectious Diseases Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Infectious Diseases Landscape Analysis

    • 6.1 West USA Infectious Diseases Landscape Analysis by Major Types

    • 6.2 West USA Infectious Diseases Landscape Analysis by Major End-Users

    7 South USA Infectious Diseases Landscape Analysis

    • 7.1 South USA Infectious Diseases Landscape Analysis by Major Types

    • 7.2 South USA Infectious Diseases Landscape Analysis by Major End-Users

    8 Middle West USA Infectious Diseases Landscape Analysis

    • 8.1 Middle West USA Infectious Diseases Landscape Analysis by Major Types

    • 8.2 Middle West USA Infectious Diseases Landscape Analysis by Major End-Users

    9 Northeast USA Infectious Diseases Landscape Analysis

    • 9.1 Northeast USA Infectious Diseases Landscape Analysis by Major Types

    • 9.2 Northeast USA Infectious Diseases Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 AstraZeneca

        • 10.1.1 AstraZeneca Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Johnson & Johnson

        • 10.2.1 Johnson & Johnson Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Eli Lilly

        • 10.3.1 Eli Lilly Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Sanofi

        • 10.4.1 Sanofi Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Novartis

        • 10.5.1 Novartis Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Mitsubishi Tanabe Pharma

        • 10.6.1 Mitsubishi Tanabe Pharma Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Gilead Sciences

        • 10.7.1 Gilead Sciences Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 AbbVie

        • 10.8.1 AbbVie Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Pfizer

        • 10.9.1 Pfizer Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Cubist

        • 10.10.1 Cubist Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Merck

        • 10.11.1 Merck Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 F Hoffmann-La Roche

        • 10.12.1 F Hoffmann-La Roche Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Isis Pharmaceuticals

        • 10.13.1 Isis Pharmaceuticals Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 GlaxoSmithKline

        • 10.14.1 GlaxoSmithKline Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Chimerix Pharmaceuticals

        • 10.15.1 Chimerix Pharmaceuticals Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Bristol-Myers Squibb

        • 10.16.1 Bristol-Myers Squibb Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

      • 10.17 Bayer

        • 10.17.1 Bayer Company Profile and Recent Development

        • 10.17.2 Market Performance

        • 10.17.3 Product and Service Introduction

      • 10.18 Vertex

        • 10.18.1 Vertex Company Profile and Recent Development

        • 10.18.2 Market Performance

        • 10.18.3 Product and Service Introduction

      • 10.19 Astellas Pharma

        • 10.19.1 Astellas Pharma Company Profile and Recent Development

        • 10.19.2 Market Performance

        • 10.19.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Infectious Diseases Market Size and Growth Rate of Influenza from 2016 to 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of HPV from 2016 to 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of Hepatitis from 2016 to 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of HIV from 2016 to 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of Tuberculosis from 2016 to 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of Hospitals/Clinical Laboratories from 2016 to 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of Reference Laboratories from 2016 to 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of Physician Offices from 2016 to 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of Academic/Research Institutes from 2016 to 2027

    • Figure USA Infectious Diseases Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Infectious Diseases Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Infectious Diseases Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Infectious Diseases Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Infectious Diseases Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Infectious Diseases Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Infectious Diseases

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Infectious Diseases by Different Types from 2016 to 2027

    • Table Consumption Share of Infectious Diseases by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Influenza

    • Figure Market Size and Growth Rate of HPV

    • Figure Market Size and Growth Rate of Hepatitis

    • Figure Market Size and Growth Rate of HIV

    • Figure Market Size and Growth Rate of Tuberculosis

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Infectious Diseases by Different End-Users from 2016 to 2027

    • Table Consumption Share of Infectious Diseases by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals/Clinical Laboratories

    • Figure Market Size and Growth Rate of Reference Laboratories

    • Figure Market Size and Growth Rate of Physician Offices

    • Figure Market Size and Growth Rate of Academic/Research Institutes

    • Figure Market Size and Growth Rate of Other

    • Table USA Infectious Diseases Production by Regions

    • Table USA Infectious Diseases Production Share by Regions

    • Figure USA Infectious Diseases Production Share by Regions in 2016

    • Figure USA Infectious Diseases Production Share by Regions in 2021

    • Figure USA Infectious Diseases Production Share by Regions in 2027

    • Table USA Infectious Diseases Consumption by Regions

    • Table USA Infectious Diseases Consumption Share by Regions

    • Figure USA Infectious Diseases Consumption Share by Regions in 2016

    • Figure USA Infectious Diseases Consumption Share by Regions in 2021

    • Figure USA Infectious Diseases Consumption Share by Regions in 2027

    • Table West USA Infectious Diseases Consumption by Types from 2016 to 2027

    • Table West USA Infectious Diseases Consumption Share by Types from 2016 to 2027

    • Figure West USA Infectious Diseases Consumption Share by Types in 2016

    • Figure West USA Infectious Diseases Consumption Share by Types in 2021

    • Figure West USA Infectious Diseases Consumption Share by Types in 2027

    • Table West USA Infectious Diseases Consumption by End-Users from 2016 to 2027

    • Table West USA Infectious Diseases Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Infectious Diseases Consumption Share by End-Users in 2016

    • Figure West USA Infectious Diseases Consumption Share by End-Users in 2021

    • Figure West USA Infectious Diseases Consumption Share by End-Users in 2027

    • Table South USA Infectious Diseases Consumption by Types from 2016 to 2027

    • Table South USA Infectious Diseases Consumption Share by Types from 2016 to 2027

    • Figure South USA Infectious Diseases Consumption Share by Types in 2016

    • Figure South USA Infectious Diseases Consumption Share by Types in 2021

    • Figure South USA Infectious Diseases Consumption Share by Types in 2027

    • Table South USA Infectious Diseases Consumption by End-Users from 2016 to 2027

    • Table South USA Infectious Diseases Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Infectious Diseases Consumption Share by End-Users in 2016

    • Figure South USA Infectious Diseases Consumption Share by End-Users in 2021

    • Figure South USA Infectious Diseases Consumption Share by End-Users in 2027

    • Table Middle West USA Infectious Diseases Consumption by Types from 2016 to 2027

    • Table Middle West USA Infectious Diseases Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Infectious Diseases Consumption Share by Types in 2016

    • Figure Middle West USA Infectious Diseases Consumption Share by Types in 2021

    • Figure Middle West USA Infectious Diseases Consumption Share by Types in 2027

    • Table Middle West USA Infectious Diseases Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Infectious Diseases Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Infectious Diseases Consumption Share by End-Users in 2016

    • Figure Middle West USA Infectious Diseases Consumption Share by End-Users in 2021

    • Figure Middle West USA Infectious Diseases Consumption Share by End-Users in 2027

    • Table Northeast USA Infectious Diseases Consumption by Types from 2016 to 2027

    • Table Northeast USA Infectious Diseases Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Infectious Diseases Consumption Share by Types in 2016

    • Figure Northeast USA Infectious Diseases Consumption Share by Types in 2021

    • Figure Northeast USA Infectious Diseases Consumption Share by Types in 2027

    • Table Northeast USA Infectious Diseases Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Infectious Diseases Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Infectious Diseases Consumption Share by End-Users in 2016

    • Figure Northeast USA Infectious Diseases Consumption Share by End-Users in 2021

    • Figure Northeast USA Infectious Diseases Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Mitsubishi Tanabe Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma

    • Table Product and Service Introduction of Mitsubishi Tanabe Pharma

    • Table Company Profile and Development Status of Gilead Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences

    • Figure Sales and Growth Rate Analysis of Gilead Sciences

    • Figure Revenue and Market Share Analysis of Gilead Sciences

    • Table Product and Service Introduction of Gilead Sciences

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Cubist

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cubist

    • Figure Sales and Growth Rate Analysis of Cubist

    • Figure Revenue and Market Share Analysis of Cubist

    • Table Product and Service Introduction of Cubist

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of F Hoffmann-La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche

    • Table Product and Service Introduction of F Hoffmann-La Roche

    • Table Company Profile and Development Status of Isis Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Isis Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Isis Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Isis Pharmaceuticals

    • Table Product and Service Introduction of Isis Pharmaceuticals

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Chimerix Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chimerix Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Chimerix Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Chimerix Pharmaceuticals

    • Table Product and Service Introduction of Chimerix Pharmaceuticals

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Vertex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vertex

    • Figure Sales and Growth Rate Analysis of Vertex

    • Figure Revenue and Market Share Analysis of Vertex

    • Table Product and Service Introduction of Vertex

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.